BMS, Systimmune ink $8 4B deal for bispecific ADC that targets EGFR, HER3
bioworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioworld.com Daily Mail and Mail on Sunday newspapers.